The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bowel and bladder toxicity patterns in patients with prostate cancer treated with proton beam versus intensity-modulated radiation therapy.
Phillip J. Gray
No relevant relationships to disclose
Jonathan J. Paly
No relevant relationships to disclose
Martin G. Sanda
No relevant relationships to disclose
Howard Mark Sandler
No relevant relationships to disclose
Jeff M. Michalski
No relevant relationships to disclose
James Austin Talcott
No relevant relationships to disclose
John Coen
No relevant relationships to disclose
William U. Shipley
No relevant relationships to disclose
Anthony L. Zietman
No relevant relationships to disclose
Justin E. Bekelman
No relevant relationships to disclose
Jason Alexander Efstathiou
No relevant relationships to disclose